← Leaderboards
Christopher S Arnold
Biocryst Pharmaceuticals, Inc.
$97,990
Attributed
$97,990
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$97,990 · 1
By mechanism
R43$97,990 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Acute Phase Protein”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Ziad Nahas · Medical University Of South Carolina$22,722,368
- Neelum T Aggarwal · Rush University Medical Center$16,273,458
- Elizabeth Phillips · University Of Cape Town$15,913,564
- Scott J Hultgren · Washington University$14,378,041
- Athan Kuliopulos · Tufts Medical Center$13,148,245
Research focus
Acute Phase ProteinAmyloid ProteinsBiomarkerCoronary DisorderDisease /Disorder ModelDrug Design /Synthesis /ProductionDrug Screening /EvaluationEnzyme ActivityEnzyme ComplexEnzyme Linked Immunosorbent AssayGenetically Modified AnimalsHigh Performance Liquid ChromatographyInflammationInterleukin 6Laboratory MouseLaboratory RabbitLipopolysaccharidesMass SpectrometryProtein MetabolismRestenosisSmall MoleculeSwineThromboplastinThrombosis